Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Samer Suleiman"'
Autor:
Korb, Christian1, Alzyod, Samer Suleiman1, Attarakih, Menwer1,2, Bart, Hans‐Jörg1 bart@mv.uni-kl.de
Publikováno v:
Chemie Ingenieur Technik (CIT). Dec2017, Vol. 89 Issue 12, p1625-1634. 10p.
Autor:
Dominique Thévenin, Monika Nanjaiah, Abouelmagd Abdelsamie, Ivan Skenderović, Cheng Chi, Samer Suleiman
Spray combustion is one of the most important applications connected to modern combustion systems. Direct numerical simulations (DNS) of such multiphase flows are complex and computationally very challenging. Ideally, such simulations account for ato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47002e37480c31636659f86cbec8a4e6
Autor:
Andreas M. Kempf, Jan Menser, Christof Schulz, Florian Schneider, E. Borukhovich, Hartmut Wiggers, Samer Suleiman, Irenäus Wlokas
Publikováno v:
The Review of scientific instruments. 90(8)
In many scientific communities, the definition of standardized experiments has enabled major progress in process understanding. The investigation of the spray-flame synthesis of nanoparticles at a well-defined standard burner by experiment and simula
Autor:
Barbara L. Andersen, William E. Carson, Catherine E. Terrell, Samer Suleiman, Lisa M. Thornton, Kimberly A. Varker, Marilyn Welt
Publikováno v:
Journal of Surgical Research. 139:36-44
Background We previously reported that cancer-related psychological stress is associated with reduced natural killer (NK) cell lysis. We hypothesized that reduced NK cell cytotoxicity in patients with increased levels of stress would correlate with a
Autor:
Alexander Kompch, Christian Notthoff, Ulf Bergmann, Ralf Theissmann, Burak Atakan, Martin Busch, Markus Winterer, Samer Suleiman
Nitrogen oxides (NOx) belong to the most common pollutants from combustion processes and are a major threat to human health. Carbon-based catalysts exhibit strong advantages for NOx removal like low-toxic application and easy handling. However, gasif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7574cc34306c04f2fda15562fe8aeef6
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84912032796
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84912032796
Autor:
Malik E. Juweid, Michael Pereira, Lawrence C. Swayne, David M. Goldenberg, George Hajjar, Thomas Herskovic, Samer Suleiman, Robert M. Sharkey, Arnold D. Rubin
Publikováno v:
Cancer. 85:1828-1842
BACKGROUND Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD),